Vivus unveils obesity management capsule in US
Qsymia requires to be taken as an adjunct to a reduced-calorie diet and increased physical activity for obesity management by patients with improper body mass index along with
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.